tasly pharmaceutical group-a (600535) Details

Tasly Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and sale of herbal medicines, chemical medicines, health products, herbal extracts, daily hygiene products, and medical equipment worldwide. Its herbal medicines include Danshen Plus capsules and CerebralCare granules; and chemical medicines comprise temozolomide, lisinopril, thiamphenicol, and flutamide capsules, as well as flutamide, sulpiride, glucurolactone, ketotifen fumarate, bezafibrate, tiapride hydrochloride, and metformin hydorchloride tablets. The company also offers health products, such as citrus sour tablets, cordyceps, propolis and water lily, I-cleansing capsules, propolis and glossy ganoderma, red yeast, royal jelly softgel, de-toxin sheet, milk calcium, and seal oil; and pharmaceutical substances and APIs. In addition, it provides herbal extracts, such as concentrated extract granules; teas for delay aging, maintain skin beauty, regulate endocrine secretion, and enhance cardio-cerebrovascular microcirculation; cosmetic products, including moisture lotions and creams, eye creams, nourishing lotions, and face washing foams; and daily hygiene products, such as soaps and sanitary pads; and medical equipment comprising B&E circulation machines, and massage cushions and tappers. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, the People’s Republic of China.

tasly pharmaceutical group-a (600535) Top Compensated Officers